{"id":"https://openalex.org/W7111237293","doi":"https://doi.org/10.14309/01.ajg.0001133980.69625.5e","title":"S1630 Upadacitinib as Salvage Therapy for Acute Severe Ulcerative Colitis: A Multi-Center Experience","display_name":"S1630 Upadacitinib as Salvage Therapy for Acute Severe Ulcerative Colitis: A Multi-Center Experience","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W7111237293","doi":"https://doi.org/10.14309/01.ajg.0001133980.69625.5e"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0001133980.69625.5e","doi":"https://doi.org/10.14309/01.ajg.0001133980.69625.5e","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001133980.69625.5e","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Isabel Lopera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Isabel Lopera","raw_affiliation_strings":["Presenter"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Presenter","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Edward V. Loftus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward V. Loftus","raw_affiliation_strings":["Presenter"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Presenter","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Guilherme Piovezani Ramos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guilherme Piovezani Ramos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Stephens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Stephens","raw_affiliation_strings":["Presenter"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Presenter","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Amanda Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Johnson","raw_affiliation_strings":["Presenter"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Presenter","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"120","issue":"10S2","first_page":"S350","last_page":"S350"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13569","display_name":"Microscopic Colitis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/upadacitinib","display_name":"upadacitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/acute-severe-ulcerative-colitis","display_name":"acute severe ulcerative colitis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7990000247955322},{"id":"https://openalex.org/keywords/colectomy","display_name":"colectomy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/clinical-remission","display_name":"clinical remission","score":0.8379999995231628},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.628000020980835},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.7739999890327454},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.6800000071525574},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.6269999742507935},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.47699999809265137},{"id":"https://openalex.org/keywords/colectomy-free-survival","display_name":"colectomy-free survival","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9797999858856201},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.7050999999046326},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6647999882698059},{"id":"https://openalex.org/C2776667177","wikidata":"https://www.wikidata.org/wiki/Q1779148","display_name":"Colectomy","level":4,"score":0.6585000157356262},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.51910001039505},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4893999993801117},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.4657999873161316},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.46230000257492065},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.3707999885082245},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.31769999861717224},{"id":"https://openalex.org/C2776485726","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Rescue therapy","level":2,"score":0.30379998683929443},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30090001225471497},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.2928999960422516},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.28519999980926514},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.2624000012874603}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0001133980.69625.5e","doi":"https://doi.org/10.14309/01.ajg.0001133980.69625.5e","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001133980.69625.5e","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.573203980922699,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"In":[1],"patients":[2,66,145,161,198,218,241,277,295,313,338],"with":[3,16,81,88,171,214,297,354],"acute":[4],"severe":[5],"ulcerative":[6],"colitis":[7],"(ASUC),":[8],"approximately":[9],"one-third":[10],"will":[11],"not":[12],"respond":[13],"to":[14,18,75,112,176,209,284,305,331,342,344,348,363],"corticosteroids,":[15],"up":[17],"20%":[19,169],"ultimately":[20],"requiring":[21],"colectomy.":[22,345],"There":[23],"has":[24],"been":[25,174],"increasing":[26],"interest":[27],"in":[28,44,51,119,123,222,237,253,272,294,371],"the":[29,265,268,332,365],"use":[30,50],"of":[31,64,84,143,197,217,240,256,274,300,312,323,334,350,369],"upadacitinib":[32],"(UPA),":[33],"a":[34,61,82,306,309],"selective":[35],"Janus":[36],"Kinase":[37],"1":[38],"Inhibitor":[39],"(JAKi),":[40],"for":[41,148,291],"rescue":[42,292],"therapy":[43,293],"these":[45,336],"patients.":[46],"Data":[47,96],"on":[48],"its":[49],"ASUC":[52,85,149],"remains":[53],"limited":[54],"warranting":[55],"further":[56],"investigation.":[57],"Methods:":[58],"We":[59],"performed":[60],"retrospective":[62],"review":[63],"all":[65,299],"aged":[67],"16":[68],"years":[69],"or":[70,79,178],"older":[71],"who":[72,242],"were":[73,97,108,146,162,251,302,339,352],"admitted":[74,147,296],"Mayo":[76],"Clinic":[77],"Rochester":[78],"Arizona":[80],"diagnosis":[83],"and":[86,101,125,137,154,261,288,317,367],"treated":[87],"UPA":[89,113,156,244,282,351,370],"from":[90,224],"February":[91],"2023":[92],"through":[93],"April":[94],"2025.":[95],"captured":[98],"during":[99,150],"admission":[100],"90":[102,321],"days":[103,322],"post":[104],"discharge.":[105,247],"Primary":[106],"outcomes":[107],"inpatient":[109],"clinical":[110,134,200,233,315],"response":[111,316],"at":[114,204],"day":[115,194,205],"3":[116,206],"(\u226550%":[117],"reduction":[118,122,221],"stool":[120],"frequency,":[121],"bleeding)":[124],"90-day":[126,133,227],"colectomy":[127,228,319],"free":[128],"survival.":[129],"Secondary":[130],"endpoints":[131],"included":[132],"remission":[135,234],"rates":[136],"adverse":[138],"events.":[139,357],"Results:":[140],"A":[141],"total":[142],"10":[144],"this":[151,325,372],"time":[152],"frame":[153],"received":[155],"45":[157],"mg":[158],"daily.":[159],"All":[160],"tumor-necrosis":[163],"factor":[164],"inhibitor":[165],"(TNFi)-exposed":[166],"(80%":[167],"IFX,":[168],"adalimumab)":[170],"60%":[172,196],"having":[173],"exposed":[175,304],"2":[177],"more":[179,340],"advanced":[180],"therapies.":[181],"On":[182],"admission,":[183],"median":[184],"CRP":[185,203,223],"was":[186,207,230,235],"61.7":[187],"mg/L":[188,211],"(interquartile":[189],"range":[190],"[IQR],":[191],"23.2-86.3).":[192],"By":[193],"3,":[195],"achieved":[199,236],"response.":[201],"Median":[202],"reduced":[208],"29.9":[210],"(IRQ,":[212],"12.4-38.6),":[213],"50%":[215,220,238],"(4/8)":[216],"achieving":[219,314],"baseline.":[225],"The":[226],"rate":[229],"20%.":[231],"Ninety-day":[232],"(3/6)":[239],"continued":[243],"following":[245],"hospital":[246],"Adverse":[248],"events":[249],"(AE)":[250],"reported":[252],"30%":[254],"(3/10)":[255],"patients,":[257],"including":[258],"acne":[259],"(20%)":[260],"drug-related":[262],"fever":[263],"(10%),":[264],"latter":[266],"being":[267],"only":[269],"AE":[270,346],"resulting":[271],"discontinuation":[273,349],"UPA.":[275],"No":[276],"developed":[278],"thromboembolic":[279,356],"complications.":[280],"Conclusion:":[281],"appears":[283],"be":[285],"an":[286],"effective":[287],"safe":[289],"option":[290],"ASUC,":[298],"whom":[301],"previously":[303],"TNFi.":[307],"With":[308],"substantial":[310],"proportion":[311],"avoiding":[318],"after":[320],"follow-up,":[324],"is":[326],"important":[327],"given":[328],"that":[329],"prior":[330],"availability":[333],"JAKi":[335],"are":[337,361],"likely":[341],"proceed":[343],"leading":[347],"minimal":[353],"no":[355],"Further":[358],"prospective":[359],"studies":[360],"needed":[362],"evaluate":[364],"efficacy":[366],"safety":[368],"population.":[373]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-12-10T00:00:00"}
